Minireview: epigenetic changes in ovarian cancer

Curt Balch1, Fang Fang, Daniela E Matei

  • 1Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana 47405-4401, USA.

Endocrinology
|July 4, 2009
PubMed
Summary

Epigenetic aberrations are key drivers in ovarian cancer development and progression. These changes, potentially reversible with epigenetic therapies, offer promising biomarkers and therapeutic targets for improved ovarian cancer interventions.